DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 67 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $28,320 | +2.7% | 2,308,028 | -0.1% | 0.00% | 0.0% |
Q2 2023 | $27,579 | +23.9% | 2,309,731 | +38.7% | 0.00% | +33.3% |
Q1 2023 | $22,259 | -52.6% | 1,664,751 | -23.7% | 0.00% | -62.5% |
Q4 2022 | $46,969 | -99.9% | 2,182,578 | +4.2% | 0.01% | +14.3% |
Q3 2022 | $41,962,000 | +14.8% | 2,094,913 | +2.6% | 0.01% | +40.0% |
Q2 2022 | $36,540,000 | +132.3% | 2,041,344 | +28.7% | 0.01% | +150.0% |
Q1 2022 | $15,731,000 | -40.9% | 1,585,741 | +0.3% | 0.00% | 0.0% |
Q4 2021 | $26,639,000 | -23.6% | 1,580,978 | +5.0% | 0.00% | -33.3% |
Q3 2021 | $34,865,000 | +4.3% | 1,506,326 | +0.1% | 0.00% | 0.0% |
Q2 2021 | $33,434,000 | – | 1,505,396 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |